Homepage
AI Research
Research
Overview
Causality
Representation Learning
Survival Analysis
Ataraxis Breast
Ataraxis Breast
Overview
Recurrence Risk
Chemotherapy Benefit
Neoadjuvant Response
Ataraxis Breast
About Us
News
Evidence
Careers
Contact Us
Copyright © 2025, ataraxis.ai, All Rights Reserved.
Homepage
AI Research
Research
Overview
Causality
Representation Learning
Survival Analysis
Ataraxis Breast
Our Tests
Ataraxis Breast
Overview
Recurrence risk (RISK)
Chemotherapy benefit (CTX)
Neoadjuvant response (NEO)
Ataraxis Breast
About Us
News
Evidence
Careers
Ordering Portal
Contact Us
Ordering Portal
Contact Us
Ordering Portal
Ataraxis lands $20.4 million Series A to accelerate clinical deployment of AI precision medicine
Read More
April 9, 2026
Press Release
Ataraxis AI Launches Ataraxis Breast NEO, a New AI Test Predicting Response to Neoadjuvant Therapy in Breast Cancer